Trials / Completed
CompletedNCT05419349
Novel Staging Schemes for Siewert Type II Esophagogastric Junction Adenocarcinoma: A Real-World Data Cohort Study From SEER Database
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,819 (actual)
- Sponsor
- Fujian Medical University Union Hospital · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This study have two aims, the first is to explore the optimal cutoff of TLN for Siewert type II AEG using the Surveillance, Epidemiology, and End Results (SEER) database the second is to provide a more accurate staging for Siewert type II AEG patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | esophagogastric junction cancer surgery | esophagogastric junction cancer surgery |
Timeline
- Start date
- 2022-06-01
- Primary completion
- 2022-06-07
- Completion
- 2022-06-07
- First posted
- 2022-06-15
- Last updated
- 2022-11-04
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05419349. Inclusion in this directory is not an endorsement.